Newsfeeds - Spark Newswire

2 minute read

Earnings

Meridian Bioscience’s Return on Invested Capital Insights

Today, 9:08 PM

According to Benzinga Pro, during Q3, Meridian Bioscience (NASDAQ:VIVO) earned $15.98 million, a 53.28% increase from the preceding quarter. Meridian Bioscience's sales decreased to $63.51 million, a 25.51% change since Q2.

VIVO

2 minute read

FDA
News

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA Or RNA From Stool Samples

By Benzinga Newsdesk

Today, 9:08 PM

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two new Air-Dryable™ Master Mixes with the launch of its

VIVO

3 minute read

Cannabis Stock Movers For September 7, 2021

By Jose Rodrigo Safdiye

Today, 9:08 PM

GAINERS: Indiva (OTC:NDVAF) shares closed up 9.76% at $0.4 with an estimated market cap of $54.3M.

ACB

1 minute read

Meridian Bioscience Expands Voluntary Recall of LeadCare Test Kits

By Vandana Singh

Today, 9:08 PM

Meridian Bioscience Inc’s (NASDAQ:VIVO) subsidiary Magellan Diagnostics Inc has expanded the Class I recall of its LeadCare Test Kits used to detect lead…

VIVO

1 minute read

Meridian Bioscience, Inc.: Magellan Diagnostics, Inc. Expands Voluntary Recall Of LeadCare Test Kits

By Bill Haddad

Today, 9:08 PM

Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. ("Magellan"), expanded

VIVO

2 minute read

Monday’s Marijuana Stock Movers

By Jose Rodrigo Safdiye

Today, 9:08 PM

GAINERS: Rhinomed (OTC:RHNMF) shares closed up 10.77% at $0.29 with an estimated market cap of $73.9M.

BLOZF

2 minute read

Cresco Labs Up By Nearly 3.5% – Here Are The Top Marijuana Stock Movers For Today

By Jose Rodrigo Safdiye

Today, 9:08 PM

GAINERS: 22nd Century Group (NASDAQ:XXII) shares closed up 9.97% at $3.97 with an estimated market cap of $646,059,867.

ACB

1 minute read

HC Wainwright & Co. Maintains Buy on Meridian Bioscience, Lowers Price Target to $27

By Benzinga Newsdesk

Today, 9:08 PM

HC Wainwright & Co. analyst Yi Chen maintains Meridian Bioscience (NASDAQ:VIVO) with a Buy and lowers the price target from $30 to $27.

VIVO

1 minute read

Body & Mind & Charlottes Web Among Top Cannabis Stock Movers On August 6, 2021

By Jose Rodrigo Safdiye

Today, 9:08 PM

GAINERS:

ARNA

1 minute read

Meridian Bioscience: Q3 Earnings Insights

By Benzinga Insights

Today, 9:08 PM

Shares of Meridian Bioscience (NASDAQ:VIVO) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share decreased 60.00% year over year to $0.22, which missed the estimate of $0.31.

VIVO